Ross J Mason (@masonrossj) 's Twitter Profile
Ross J Mason

@masonrossj

Urologist and Surgical Oncologist at Dalhousie University | Canadian trained surgeon | Father and husband

ID: 782575619150196737

calendar_today02-10-2016 13:39:01

123 Tweet

172 Followers

230 Following

DalUrology (@dalurology) 's Twitter Profile Photo

Wishing we were at #AUA2020! @SKimMD1 MP50-05: How well does renal mass size measured by ultrasound correlate with measurements obtained by CT, MRI or pathology? Analysis from the Canadian Kidney Cancer Information System cdmcd.co/zx8RE3  #AUAVirtualSci

Society of Urologic Oncology (@uroonc) 's Twitter Profile Photo

📢 Don't forget the second session in the YUO webinar series is next Monday, Oct 12! Join Dave Penson, Amy Luckenbaugh, and Christopher Wallis (he/him/his) as they discuss pertinent issues across all urology sub-specialties. Register here: suonet.org/meetings/event…

OncLive.com (@onclive) 's Twitter Profile Photo

Reduction in PSA Screening Associated with Increased Incidence of Metastatic Prostate Cancer in the United States Vidit Sharma Mayo Clinic ASCO #GU21 #pcsm ow.ly/dXZI50DzFXs

Matt Cooperberg (@dr_coops) 's Twitter Profile Photo

I was just sent this from a patient - omg for anyone who thought "prostatectomy comedy" is an oxymoron, give this the next 2.5 minutes of your full attention! Phenomenal. Many thanks MarshFamilySongs. #pcsm #prostatecancer #UroSoMe youtu.be/Vr-7z3xj9-4 via YouTube

CUAJournal (@cuajournal) 's Twitter Profile Photo

#CUAJvideo🎬 Dr. Jesse Spooner discusses: Impact of virtual education on urology education during the COVID-19 pandemic>> To read: cuaj.ca/index.php/jour… Adriana Modica Mike Leveridge Jesse Spooner Dalhousie University

UroToday.com (@urotoday) 's Twitter Profile Photo

PC-PEP, a comprehensive daily 6-month home-based #ProstateCancer - Patient empowerment program improves QoL, physical fitness, and urinary function outcomes among #PCa patients with localized disease: secondary analyses Gabriela Ilie > bit.ly/46BE3xx #ESMO23 Rashid K. Sayyid

PC-PEP, a comprehensive daily 6-month home-based #ProstateCancer - Patient empowerment program improves QoL, physical fitness, and urinary function outcomes among #PCa patients with localized disease: secondary analyses <a href="/GabrielaIDr/">Gabriela Ilie</a> &gt; bit.ly/46BE3xx #ESMO23 <a href="/RKSayyid/">Rashid K. Sayyid</a>
Tom Powles (@tompowles1) 's Twitter Profile Photo

Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%). Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% & 29% is hard to beat. DOR not reached (1/3)#ESMO2023

Enfortumab vedotin &amp; Pembrolizumab improving PFS &amp; OS by 55% &amp; 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%).  Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% &amp; 29% is hard to beat. DOR not reached (1/3)#ESMO2023